England and Wales reject Leo Pharma's eczema drug
![Photo: Leo Pharma / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13914120.ece/ALTERNATES/schema-16_9/doc7kiluwvpppw7vzwo69v.jpg)
The public body responsible for providing guidance and advice for England and Wales, the National Institute for Health and Care Excellence (NICE), has announced in a press release that it does not recommend Leo Pharma’s Adtralza (tralokinumab) as a treatment for atopic dermatitis.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.